Report: Developing Opportunities within Teleflex, Anthem, Crown Castle International, MSCI, GCI Liberty, and Akebia Therapeutics — Future Expectations, Projections Moving into 2018


NEW YORK, Nov. 29, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Teleflex Incorporated (NYSE:TFX), Anthem, Inc. (NYSE:ANTM), Crown Castle International Corporation (NYSE:CCI), MSCI Inc (NYSE:MSCI), GCI Liberty, Inc. (NASDAQ:GLIBA), and Akebia Therapeutics, Inc. (NASDAQ:AKBA), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

TFX DOWNLOAD: http://MarketSourceResearch.com/register/?so=TFX
ANTM DOWNLOAD: http://MarketSourceResearch.com/register/?so=ANTM
CCI DOWNLOAD: http://MarketSourceResearch.com/register/?so=CCI
MSCI DOWNLOAD: http://MarketSourceResearch.com/register/?so=MSCI
GLIBA DOWNLOAD: http://MarketSourceResearch.com/register/?so=GLIBA
AKBA DOWNLOAD: http://MarketSourceResearch.com/register/?so=AKBA

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Market Source Research, available for free download at the links above, examine Teleflex Incorporated (NYSE:TFX), Anthem, Inc. (NYSE:ANTM), Crown Castle International Corporation (NYSE:CCI), MSCI Inc (NYSE:MSCI), GCI Liberty, Inc. (NASDAQ:GLIBA), and Akebia Therapeutics, Inc. (NASDAQ:AKBA) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed November 27th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

TELEFLEX INCORPORATED (TFX) REPORT OVERVIEW

Teleflex's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Teleflex reported revenue of $609.67MM vs $534.70MM (up 14.02%) and analysts estimated basic earnings per share $1.23 vs $1.71 (down 28.07%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Teleflex reported revenue of $2,146.30MM vs $1,868.03MM (up 14.90%) and analysts estimated basic earnings per share $3.39 vs $5.48 (down 38.14%). Analysts expect earnings to be released on February 28th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $2.44. The estimated EPS forecast for the next fiscal year is $11.20 and is expected to report on February 28th, 2019.

To read the full Teleflex Incorporated (TFX) report, download it here: http://MarketSourceResearch.com/register/?so=TFX

-----------------------------------------

ANTHEM, INC. (ANTM) REPORT OVERVIEW

Anthem's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Anthem reported revenue of $23,251.00MM vs $22,426.00MM (up 3.68%) and analysts estimated basic earnings per share $3.70 vs $2.87 (up 28.92%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Anthem reported revenue of $90,039.40MM vs $84,863.00MM (up 6.10%) and analysts estimated basic earnings per share $14.70 vs $9.39 (up 56.55%). Analysts expect earnings to be released on January 30th, 2019. The report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same quarter last year was $1.29. The estimated EPS forecast for the next fiscal year is $17.59 and is expected to report on January 30th, 2019.

To read the full Anthem, Inc. (ANTM) report, download it here: http://MarketSourceResearch.com/register/?so=ANTM

-----------------------------------------

CROWN CASTLE INTERNATIONAL CORPORATION (CCI) REPORT OVERVIEW

Crown Castle International's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Crown Castle International reported revenue of $1,375.00MM vs $1,063.00MM (up 29.35%) and analysts estimated basic earnings per share $0.33 vs $0.22 (up 50.00%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Crown Castle International reported revenue of $4,355.61MM vs $3,921.23MM (up 11.08%) and analysts estimated basic earnings per share $1.01 vs $0.95 (up 6.32%). Analysts expect earnings to be released on January 23rd, 2019. The report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same quarter last year was $1.25. The estimated EPS forecast for the next fiscal year is $5.60 and is expected to report on January 23rd, 2019.

To read the full Crown Castle International Corporation (CCI) report, download it here: http://MarketSourceResearch.com/register/?so=CCI

-----------------------------------------

MSCI INC (MSCI) REPORT OVERVIEW

MSCI's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, MSCI reported revenue of $357.93MM vs $322.10MM (up 11.13%) and basic earnings per share $1.39 vs $0.94 (up 47.87%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, MSCI reported revenue of $1,274.17MM vs $1,150.67MM (up 10.73%) and analysts estimated basic earnings per share $3.36 vs $2.72 (up 23.53%). Analysts expect earnings to be released on February 7th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $1.15. The estimated EPS forecast for the next fiscal year is $5.94 and is expected to report on February 7th, 2019.

To read the full MSCI Inc (MSCI) report, download it here: http://MarketSourceResearch.com/register/?so=MSCI

-----------------------------------------

GCI LIBERTY, INC. (GLIBA) REPORT OVERVIEW

GCI Liberty's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, GCI Liberty reported revenue of $210.15MM vs $5.49MM (up 3,725.71%) and analysts estimated basic earnings per share $2.95 vs $2.64 (up 11.74%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, GCI Liberty reported revenue of $919.20MM vs $933.81MM (down 1.56%) and analysts estimated basic earnings per share -$0.70 vs -$0.10. Analysts expect earnings to be released on February 14th, 2019. The report will be for the fiscal period ending December 31st, 2018. The estimated EPS forecast for the next fiscal year is -$0.46 and is expected to report on February 14th, 2019.

To read the full GCI Liberty, Inc. (GLIBA) report, download it here: http://MarketSourceResearch.com/register/?so=GLIBA

-----------------------------------------

AKEBIA THERAPEUTICS, INC. (AKBA) REPORT OVERVIEW

Akebia Therapeutics' Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Akebia Therapeutics reported revenue of $53.17MM vs $41.28MM (up 28.79%) and analysts estimated basic earnings per share -$0.46 vs -$0.49. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Akebia Therapeutics reported revenue of $177.98MM vs $1.54MM (up 11,495.05%) and analysts estimated basic earnings per share -$1.77 vs -$3.60. Analysts expect earnings to be released on March 11th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.25. The estimated EPS forecast for the next fiscal year is -$2.75 and is expected to report on March 11th, 2019.

To read the full Akebia Therapeutics, Inc. (AKBA) report, download it here: http://MarketSourceResearch.com/register/?so=AKBA

-----------------------------------------

ABOUT MARKET SOURCE RESEARCH

Market Source Research delivers the key research reports that helps serious investors, registered brokers, professional traders, and personal investment advisers find reliable information in today's markets. Market Source Research's team is comprised of financial professionals, many of which hold Chartered Financial Analyst® (CFA®) designations and FINRA® BrokerCheck® certifications. Whether identifying emerging trends, or discovering new opportunity, the team at Market Source Research is dedicated to providing accurate, informative, and objective content that's ahead of the curve. With insights on individual companies as well as sectors, readers get the industry's best available combination of big-picture perspective as well as granular detail.

REGISTERED MEMBER STATUS

Market Source Research's oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Market Source Research's roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Market Source Research have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Market Source Research's Compliance department by Phone, at +1 (704) 343-6361, or by E-mail at compliance@MarketSourceResearch.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Market Source Research, Market Source Research members, and/or Market Source Research affiliates are not responsible for any gains or losses that result from the opinions expressed. Market Source Research makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Market Source Research has not been compensated for the publication of this press release by any of the above mentioned companies. Market Source Research is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Hugo Moreau, Media Department
Office: +1 (704) 343-6361
E-mail: media@MarketSourceResearch.com

© 2018 Market Source Research. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@MarketSourceResearch.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.